THU0214 Long-term outcome of iguratimod, conventional synthetic disease-modifyng anti-rheumatic drud developed in japan, in japanese patients with rheumatoid arthritis in real-world clinical setting
THU0214 Long-term outcome of iguratimod, conventional synthetic disease-modifyng anti-rheumatic drud developed in japan, in japanese patients with rheumatoid arthritis in real-world clinical setting